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DNA methylation is essential for development and in
diverse biological processes. The DNA methyltrans-
ferase Dnmt1 maintains parental cell methylation
patterns on daughter DNA strands in mitotic cells;
however, the precise role of Dnmt1 in regulation of
quiescent adult stem cells is not known. To examine
the role of Dnmt1 in adult hematopoietic stem cells
(HSCs),weconditionallydisruptedDnmt1 in thehema-
topoietic system. Defects were observed in Dnmt1-
deficient HSC self-renewal, niche retention, and in
the ability of Dnmt1-deficient HSCs to give rise tomul-
tilineage hematopoiesis. Loss of Dnmt1 also had
specific impact on myeloid progenitor cells, causing
enhanced cell cycling and inappropriate expression
of mature lineage genes. Dnmt1 regulates distinct
patterns of methylation and expression of discrete
gene families in long-term HSCs and multipotent and
lineage-restricted progenitors, suggesting that Dnmt1
differentially controls these populations. These find-
ings establish a unique and critical role for Dnmt1 in
the primitive hematopoietic compartment.
INTRODUCTION
DNA methylation is an epigenetic mechanism essential for
normal development, influencing cellular events such as tran-
scription, genomic imprinting, and genome stability (Jaenisch,
1997). DNA methyltransferases (Dnmts) are the group of enzymes
responsible for establishment and maintenance of genomic DNA
methylation. They include the de novo methyltransferases
Dnmt3a and Dnmt3b and the maintenance methyltransferase
Dnmt1. All three are essential genes for embryonic development
(Lei et al., 1996; Li et al., 1992; Okano et al., 1999) and have been
shown to be critical for survival of many somatic cell types,
including mouse embryonic fibroblasts (Jackson-Grusby et al.,
2001) and CNS neurons (Fan et al., 2001). This is in clear contrast
to embryonic stem cells, which can be derived and maintain their
stem cell properties without Dnmt1, Dnmt3a, or Dnmt3b, essen-
tially in the absence of DNA methylation (Tsumura et al., 2006).442 Cell Stem Cell 5, 442–449, October 2, 2009 ª2009 Elsevier Inc.The question remains as to whether adult somatic stem cells
are critically regulated by DNA methylation, like their differenti-
ated counterparts, or are less dependent upon DNA methylation
and thus more similar to embryonic stem cells.
Interestingly, a conditional knockout study of the de novo
methyltransferases Dnmt3a and Dnmt3b in adult hematopoietic
stem cells (HSCs) demonstrated that DNA methylation by these
enzymes is critical for self-renewal of HSCs but not for their
differentiation to progenitors and mature cells (Tadokoro et al.,
2007). Here, we utilized an inducible, conditional knockout
approach to examine consequences of loss of the maintenance
methyltransferase Dnmt1 in HSCs and hematopoiesis in vivo.
We demonstrate that Dnmt1 is essential for HSC self-renewal,
niche retention, and proper differentiation of the myeloid lineage.
We suggest that adult somatic stem cell fate transitions, critical
for stepwise differentiation, changes in cycling, and the process
of mobilization, are especially dependent upon maintenance
methylation induced by Dnmt1.
RESULTS
Dnmt1 Loss Impairs Contribution of HSCs
and Progenitors to Hematopoiesis
To evaluate the role of Dnmt1 in maintenance of hematopoiesis,
we utilized Dnmt1fl/fl mice (Jackson-Grusby et al., 2001). Cross-
ing Dnmt1fl/fl and Gata1-Cre transgenic mice to elicit germline
deletion (Jasinski et al., 2001) resulted in no viable Dnmt1-defi-
cient (Dnmt1D/D) animals (Table S1 available online), consistent
with the embryonic lethal phenotype of conventional Dnmt1
knockout mice (Li et al., 1992). We then inactivated Dnmt1 in
the hematopoietic system by breeding Dnmt1fl/fl with inter-
feron-inducible Mx-Cre transgenic animals (Figure 1A). Genomic
PCR and western blot from whole BM confirmed Dnmt1 deletion
(Figures 1B and 1C). Analysis of the peripheral blood (PB) of
control (Mx-CreDnmt1fl/fl, pIpC injected) and Dnmt1D/D mice
revealed comparable numbers of PB leukocytes, platelets,
red blood cells (RBCs), and hemoglobin levels (Figure 1D). At
12 weeks after pIpC, no changes were found in Dnmt1D/D PB
lineage distribution, total BM cellularity, or BM lineage composi-
tion (Figure S1). These data demonstrate that hematopoiesis is
essentially normal in the absence of Dnmt1.
BecauseMx-Cre has been observed to induce deletion in both
hematopoietic cells and the BM microenvironment (Walkley et al.,
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Dnmt1 Regulates HSCs and Progenitor CellsFigure 1. Conditional Deletion of Dnmt1 Results in Primitive Hematopoietic Cell Defects
(A) Experimental scheme.
(B) Genomic PCR from control (Dnmtfl/fl Cre) or Dnmt1D/D (Dnmtfl/fl Cre+) BM for Dnmt1 and b-actin.
(C) Western blot analysis of Dnmt1 in control and Dnmt1D/D BM before and 6 weeks after pIpC.
(D) Differential PB counts in control and Dnmt1D/D mice before and after pIpC. Data expressed as mean ± SD; nR 3 mice per genotype.
(E) Average PB chimerism of control or Dnmt1D/D BM cells after transplant into lethally irradiated recipients. Data expressed as mean ± SD; n = 4 recipients per
group; *p < 0.05, **p < 0.01.
(F) Average BM chimerism of control or Dnmt1D/D cells at 20 weeks posttransplant. Data expressed as mean + SD; n = 4 recipients per group; *p < 0.05, **p < 0.01.
(G) Average BM chimerism within secondary transplant recipients at 16 weeks posttransplant. Data expressed as mean + SD; n = 3 recipients per group;
*p < 0.05, **p < 0.01.2007), we adopted a transplantation strategy to determine
the intrinsic role of Dnmt1 in HSCs and progenitors. Whole BM
fromMx-CreDnmt1fl/fl orMx-Cre+Dnmt1fl/fl mice (both CD45.2+)
was transplanted into lethally irradiated recipient mice (CD45.1+),
and all mice were treated with pIpC at 4 weeks after transplant.
After pIpC treatment, the PB chimerism of Dnmt1D/D cells
was significantly decreased and continued to decline over the
following 12 weeks (Figure 1E). By 20 weeks after transplant,
Dnmt1D/D cells were able to generate only 50%–80% of mature
cells in the BM (Figure 1F). Donor CD45.2+ BM cells were then
reisolated and injected into secondary recipients. This revealed
a further reduction in the ability of Dnmt1D/D HSCs to generate
mature cells (Figure 1G). Interestingly, the contribution of
Dnmt1D/D HSCs to the myeloid lineage was most significantly
affected as opposed to the lymphoid lineages (Figure 1G).
Thus, Dnmt1 is required for presumptive self-renewal divisions
of HSCs as well as differentiation, with particular defects
observed in the ability of Dnmt1D/D HSCs to generate mature
myeloid cells.CDnmt1 Is Required for HSC Self-Renewal
We further evaluated Dnmt1D/DHSC functional capacity in a com-
petitive repopulation assay. Whole BM from Mx-CreDnmt1fl/fl
or Mx-Cre+Dnmt1fl/fl mice was transplanted at a 1:1 ratio with
wild-type (WT) competitor BM (CD45.1+CD45.2+) into lethally
irradiated recipient mice and all mice were treated with pIpC at
4 weeks posttransplant (Figure 2A). After pIpC, the PB chimerism
of Dnmt1D/D cells was significantly decreased and continued to
decline over 16 weeks (Figure 2B). At 20 weeks posttransplant,
Dnmt1D/D cells were able to generate only 5%–20% of mature
cells in the BM (Figure 2C). To closely examine this defect, we
evaluated the kinetics of loss of PB multilineage cells. The initial
contribution of Mx-CreDnmt1fl/fl or Mx-Cre+Dnmt1fl/fl cells to
mature myeloid and lymphoid lineages was equivalent (Fig-
ure 2D). By 4 weeks after pIpC, the contribution of Dnmt1D/D cells
to the myeloid lineage was barely detectable and remained low
for 16 weeks (Figure 2D). In contrast, the contribution of
Dnmt1D/D cells to the B and T lymphoid lineages remained at
levels equal to or greater than control (Figure 2D). These resultsell Stem Cell 5, 442–449, October 2, 2009 ª2009 Elsevier Inc. 443
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(A) Experimental scheme.
(B) Average PB chimerism of control or Dnmt1D/D BM cells after competitive transplantation into lethally irradiated recipients. Data expressed as mean ± SD; n = 3
recipients per group; **p < 0.01, ***p < 0.001.
(C) Average BM chimerism of control or Dnmt1D/D cells at 20 weeks posttransplant. Data expressed as mean + SD; n = 3 recipients per genotype; **p < 0.01.
(D) PB chimerism of control or Dnmt1D/D BM cells in individual, mature hematopoietic lineages in primary transplant recipients. Data points represent individual
mice; *p < 0.05, **p < 0.01.
(E) PB chimerism after secondary competitive transplantation. Data points represent individual mice.demonstrate that the myeloid lineage is particularly sensitive to
Dnmt1 loss in the context of competition with WT BM cells. To
assess the self-renewal capacity of Dnmt1D/D HSCs, donor BM
cells were reisolated at 20 weeks posttransplant, mixed with
fresh competitor BM cells, and injected into secondary recipient
mice. Dnmt1D/D HSCs were unable to engraft secondary recipi-
ents in the presence of WT BM cells (Figure 2E). This phenotype
may be accounted for by several mechanisms, including
decreased self-renewal, defects in homing to the BM niche, or
niche retention.
Dnmt1 Deletion Results in Defects
in BM Niche Retention
To evaluate the mechanism of action of Dnmt1 loss on HSC
engraftment, we first assessed the ability of HSCs and progen-444 Cell Stem Cell 5, 442–449, October 2, 2009 ª2009 Elsevier Inc.itor cells to home to the BM by intravenous (i.v.) injection of
CFSE-labeled control and Dnmt1D/D LinSca-1+ cells into
lethally irradiated hosts. No difference was observed in the ability
of Dnmt1D/D CFSE+ cells to home to the BM compared to control
cells (Figure 3A). The ability of Dnmt1-deficient HSCs to be re-
tained in the BM niche was examined by nonablative transplant
where whole BM or purified long-term HSCs (LT-HSCs,
LKS+CD34/lo) from WT mice (CD45.1+CD45.2+) were trans-
planted into control or Dnmt1D/D mice (Figure 3B). The level of
engraftment of WT cells into unconditioned control animals
was similar to background staining (Figure 3C), indicating that
the HSC niche space in the BM remains stably occupied by
host cells. Comparatively, the level of engraftment of WT cells
into unconditioned Dnmt1D/D mice is nearly 50-fold higher (Fig-
ure 3C), demonstrating that Dnmt1D/D HSCs are outcompeted
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(A) Representative FACS plots of recipient BM at 16 hr posttransplant of CFSE-labeled control or Dnmt1D/D Lin Sca-1+ BM cells. Data expressed as mean ±
SEM; n = 3 recipient mice per genotype.
(B) Experimental scheme.
(C) Representative FACS plots of BM from control or Dnmt1D/D mice (CD45.2+) at 12 weeks post nonablative transplant of WT BM or LT-HSCs (CD45.1+CD45.2+).
A mock-injected recipient is shown as a control for background staining.
(D) Average number of LT-HSCs and ST-HSC/MPPs in control or Dnmt1D/D BM (femurs + tibiae). Data expressed as mean + SD; n = 3 per genotype.
(E) Heat map of HSC self-renewal and mobilization-related genes demonstrating fold expression changes (log2) in Dnmt1
D/D LT-HSCs, ST-HSC/MPPs, and
myeloid progenitors compared to control.for presence in the BM niche by WT cells. Taken together, these
data indicate that retention within the BM niche, rather than
homing to the niche, contribute to the observed defect in
Dnmt1-deficient HSC engraftment. Interestingly, the total num-
ber of LT-HSCs and short-term HSCs/multipotent progenitors
(ST-HSC/MPPs, LKS+CD34+) within the BM of Dnmt1D/D mice
were not significantly different from controls (Figure 3D), indi-cating that these cells are retained in the BM in the absence of
competing WT cells.
Methylation and Transcription Are Distinctly Altered
in Stem and Progenitor Cells upon Dnmt1 Loss
To determine the molecular mechanism underlying the observed
defects in Dnmt1-deficient HSCs, we performed global geneCell Stem Cell 5, 442–449, October 2, 2009 ª2009 Elsevier Inc. 445
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short-term consequences of Dnmt1 deletion (4 days after pIpC)
to favor identification of the most direct effects of Dnmt1 loss.
We first examined DNA methylation of the well-characterized
intracisternal A-type particle (IAP), an endogenous retrotrans-
posable element that is methylated in somatic cells by Dnmt1
(Gaudet et al., 2004). Bisulfite sequencing of the IAP promoter
region demonstrated an extensive reduction in methylation in
Dnmt1D/D LT-HSCs, ST-HSC/MPPs, and myeloid progenitors
(Figure S2A). Consistent with this loss in methylation, IAP tran-
script was upregulated in these populations (Figure S2B).
Having confirmed in our system that the loss of Dnmt1 dere-
presses a known target, we then compared gene expression
profiles of Dnmt1D/D versus control LT-HSCs, ST-HSC/MPPs,
and myeloid progenitors (denoted ‘‘Cre+/Cre’’). 484 genes
were found to be differentially expressed with an absolute fold
change >1 (Figure S3 and Table S2). Selected candidates were
validated by real-time PCR (Figure S4). Overall, the expression
changes in Dnmt1D/D LT-HSCs, ST-HSC/MPPs, and myeloid
progenitors (Figure S3) suggest that Dnmt1 regulates distinct
patterns of gene expression in subsets of hematopoietic stem
and progenitor cells. For example, carbonic anhydrase I (Car1),
an early marker of erythroid differentiation (Villeval et al., 1985),
was upregulated specifically in Dnmt1D/D ST-HSC/MPPs but
not in LT-HSCs or myeloid progenitors (Figures S5A and S5B).
Methylation of the Car1-proximal promoter was high (85%–
98%) in LT-HSCs and ST-HSC/MPPs, and Dnmt1 loss resulted
in extensive demethylation (Figure S5C). In contrast, myeloid
progenitors were observed to have low-level methylation (42%)
and loss of Dnmt1 correlated with an increase in methylation
(Figure S5C). These results suggest that (1) demethylation of
the Car1 locus in LT-HSCs is not sufficient to activate gene tran-
scription, (2) another enzyme is able to methylate the Car1 pro-
moter in the absence of Dnmt1 in myeloid progenitors, and (3)
Dnmt1 maintains distinct patterns of methylation and gene ex-
pression in LT-HSCs, ST-HSC/MPPs, and myeloid progenitors.
To further pursue the molecular mechanism underlying
Dnmt1D/D phenotypic defects, we examined genes involved in
the processes of HSC self-renewal and BM niche retention.
Genes implicated in HSC mobilization and homing (N-cadherin,
Casr, Gnas, Rac1, Rac2, Cxcr4, CD49D, Egr1) did not show
significant changes upon Dnmt1 loss (data not shown). Genes
associated with HSC self-renewal (including Tgm2, Gja1, Thy1,
Cttn, Gata1, and Klf4) were found to be increased in expression
in Dnmt1D/D LT-HSCs (Figure 3E), which does not account for
reduced self-renewal of these cells. Two genes associated
with HSC function, CD62L and Ski, were downregulated specif-
ically in Dnmt1D/D LT-HSCs (Figure 3E). Although this may
partially account for our observed phenotype, this data set over-
all supports the existence of novel, uncharacterized regulators of
HSC function to be explored from candidates in our microarray
data set after loss of Dnmt1.
Dnmt1 Regulates Cycling and Transcriptional Lineage
Fidelity of the Myeloid Progenitor Pool
Additional, potential contributors to the Dnmt1D/D phenotype
include defects in the ability of HSCs to give rise to multipotent
and lineage-restricted progenitor cells. Dnmt1D/D LT-HSCs and
ST-HSC/MPPs were found to have decreased ability to generate446 Cell Stem Cell 5, 442–449, October 2, 2009 ª2009 Elsevier Inc.myeloid colonies in the in vitro colony-forming unit assay
(Figure 4A). Examining the myeloid progenitor compartment
within the BM of Dnmt1D/D mice revealed decreased frequencies
of common myeloid progenitors (CMP, LKSIL-7RaFcgRlo
CD34+), granulocyte-macrophage progenitors (GMP, LKSIL-
7RaFcgRhiCD34+), and megakaryocyte-erythrocyte progeni-
tors (MEP, LKSIL-7RaFcgRloCD34) at 4 days after pIpC
(Figure 4B). These data demonstrate that the myeloid-restricted
progenitor compartment is acutely affected in Dnmt1D/D mice.
Loss of myeloid-restricted progenitors may be due to alter-
ations in apoptosis, cell cycling, and/or differentiation. Acute
loss of Dnmt1 was not found to impact the frequencies of
apoptotic (AnnexinV+7AAD) or dead (AnnexinV+7AAD+) cells
in total BM, CMPs, GMPs, or MEPs (Figures S6A and S6B).
Although it remains a possibility that these cells are decreased
in viability but cleared too rapidly from the system to observe
changes, we found by gene ontology (GO) analysis that
the molecular signature of apoptosis is underrepresented in
ST-HSC/MPPs and not altered in LT-HSCs or myeloid progeni-
tors (Figure S6C), supporting that apoptosis does not account
for the loss of Dnmt1D/D myeloid progenitors. To examine cell
proliferation, we analyzed cell cycle status by BrdU incorporation
(Figure 4C). Dnmt1D/D mice demonstrated significantly increased
percentages of CMPs, GMPs, and MEPs in the S phase
compared to controls (Figure 4D). This increase in cycling was
further supported by higher transcript expression of Ccnd1
(Cyclin D1) in Dnmt1D/D myeloid-restricted progenitors (LKS)
(Figure 4E). Taken together, these results suggest a concomitant
increase in cycling but decrease in overall frequency of Dnmt1D/D
myeloid progenitors that cannot be accounted for by increased
apoptosis.
To gain insight into a potential functional mechanism that can
explain why increased cycling does not lead to myeloid accumu-
lation/expansion and neutrophilia in Dnmt1D/D mice, we revisited
our GO analysis and observed that genes upregulated in
Dnmt1D/D myeloid progenitors are significantly enriched in
immunoglobulin and immune system-related GO terms (Fig-
ure 4F). Selected genes from within these GO terms, including
the histocompatibility regions H2-D1 and H2-T22 as well as
the tetraspanin CD81, were confirmed to be upregulated in
Dnmt1D/D myeloid-restricted progenitors (Figure 4G). This
suggests that Dnmt1 is involved in maintaining myeloid progen-
itors in their primitive state through suppressing transcription of
more differentiated lineage programs. Together, increased
cycling and differentiation of Dnmt1D/D myeloid-restricted
progenitors, coupled with defects in differentiation of Dnmt1D/D
LT-HSCs and ST-HSC/MPPs to replace these cells, offers
a mechanism by which the myeloid progenitor pool is lost over
time. This process may be exacerbated when in competition
with WT cells, where we see a more acute loss of the mature
myeloid lineages.
DISCUSSION
Here, we have examined effects of conditional deletion of Dnmt1
on the hematopoietic system. Mature hematopoietic lineages
were unaffected by loss of Dnmt1; however, this enzyme was
required for HSC self-renewal, niche retention, and differentia-
tion. In addition, Dnmt1 deletion resulted in increased cycling
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Dnmt1 Regulates HSCs and Progenitor CellsFigure 4. Dnmt1 Deletion Impacts Cycling and Transcription of Myeloid Progenitors
(A) Total number of colony-forming units (CFU) generated from 5000 control or Dnmt1D/D LT-HSCs or ST-HSC/MPPs; n = 3 mice per genotype; ***p < 0.0001.
(B) Frequency of CMPs, GMPs, and MEPs in lineage-depleted control or Dnmt1D/D BM; n = 3 per genotype; *p < 0.05, **p < 0.01.
(C) Representative FACS plot of BM cells in G0/G1, S, or G2/M cell cycle phases based on incorporation of BrdU and 7AAD.
(D) Average frequency of control or Dnmt1D/D CMPs, GMPs, and MEPs in S phase. Data expressed as mean + SD; n = 3 mice per genotype; *p < 0.05, **p < 0.01.
(E) Real-time PCR analysis of CyclinD1 in control or Dnmt1D/D myeloid progenitors. Data expressed as mean + SD; n = 3 mice per genotype.
(F) GO analysis of immunoglobulin-related genes upregulated in Dnmt1D/D LT-HSCs, ST-HSC/MPPs, and myeloid progenitors. GO terms with a p value less than
1E-4 are considered significantly enriched and indicated by asterisks.
(G) Real-time PCR analysis of H2-D1, H2-T22, and CD81 transcripts in control or Dnmt1D/D myeloid progenitors. Data expressed as mean + SD; n = 3 mice
per genotype.and differentiation of the myeloid-restricted progenitor pool.
DNA methylation and global gene expression analyses revealed
that Dnmt1 regulates distinct patterns of methylation and gene
expression in HSCs, multipotent progenitors, and lineage-
restricted progenitors.
Mature cells of the hematopoietic system were found to be
stable after deletion of Dnmt1; however, we observed impaired
hematopoiesis when Dnmt1 was deleted after transplantation
and when WT cells were transplanted into Dnmt1-deficient
recipients. There are at least two explanations that may account
for this: (1) the time point at which we assessed steady-stateeffects (12 weeks after pIpC) may not be long enough to observe
modest self-renewal and differentiation defects of HSCs and
progenitor cells in the absence of competing WT cells, and (2)
the DNA methyltransferases Dnmt3a and 3b may be able to
partially compensate for loss of Dnmt1 in certain contexts. This
is consistent with our observation of increased methylation of
the proximal promoter of Car1 in Dnmt1D/D myeloid-restricted
progenitors.
The hematopoietic phenotype observed after Dnmt1 deletion
is complex and appears to involve most of the primitive hemato-
poietic compartment including HSCs, multipotent, and myeloidCell Stem Cell 5, 442–449, October 2, 2009 ª2009 Elsevier Inc. 447
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are accounted for by decreased niche retention, decreased
self-renewal capacity, and differentiation defects. The enhanced
proliferative activity of Dnmt1-deficient myeloid progenitors
coupled with differentiation indicates stress on the system to
produce more mature myeloid cells. Although all of these func-
tional consequences of Dnmt1 deletion will certainly compound
and contribute to one another in an in vivo setting, it was inter-
esting to see the wide variety of gene expression changes and
different methylation patterns after acute loss of Dnmt1 in
LT-HSCs, ST-HSC/MPPs, and myeloid progenitors. Within the
ST-HSC/MPP population, in the case of both IAP and Car1,
loss of methylation was associated with activation of gene
expression. It is possible then that the ST-HSC/MPP population
is most directly regulated by Dnmt1 or by loss of methylation
maintained by Dnmt1, as opposed to the LT-HSC or myeloid
progenitor populations. Comprehensive methylation profiling in
the presence and absence of Dnmt1, Dnmt3a, and Dnmt3b,
coupled with global gene expression analysis, will provide a
means to systematically classify gene loci that are regulated
by the various Dnmts in hematopoietic stem and progenitor
populations.
Certainly, our evidence suggests that epigenetic regulation, at
least with respect to DNA methylation, of adult stem cells is
distinct from embryonic stem cells and other somatic cell types.
For example, there are clear distinctions between functional
roles of de novo methylation and maintenance methylation. De
novo methylation induced by Dnmt3a and Dnmt3b is necessary
for LT-HSC self-renewal but not differentiation (Tadokoro et al.,
2007). In contrast, we have observed that maintenance methyl-
ation induced by Dnmt1 is especially important for HSC and
progenitor cell state transitions, such as the stepwise differenti-
ation of HSCs to ST-HSC/MPPs, ST-HSC/MPPs to myeloid
progenitors, mobilization, and regulating cell cycle entry. We
suggest that these unique roles of Dnmt1 may be a common
mechanism by which maintenance methylation regulates cell
state transitions of adult somatic stem cells.
EXPERIMENTAL PROCEDURES
Experimental Animals
Dnmt1fl/fl mice generously provided by Dr. L. Jackson-Grusby (Children’s
Hospital Boston, Boston, MA, USA) (Jackson-Grusby et al., 2001) and Mx1-
Cre transgenic mice (Kuhn et al., 1995) were maintained on a C57BL/6 back-
ground. pIpC (Sigma) was administered via i.p. injection as described at
a dose of 25 mg/kg (Hock et al., 2004). To confirm deletion of Dnmt1, genomic
DNA was extracted from whole BM and PCR genotyped with described primers
(Jackson-Grusby et al., 2001). The Children’s Hospital Boston Animal Ethics
Committee approved all experiments.
Western Blot Analysis
Whole-cell lysates from control or Dnmt1D/D BM cells were separated by SDS-
PAGE. Proteins were detected by a Dnmt1 mouse monoclonal antibody
(Active Motif) and HRP-conjugated goat anti-mouse IgG1 (Novus Biologicals)
or HRP-conjugated b-actin (Abcam).
Flow Cytometry Analysis
Single-cell suspensions of BM were prepared from pooled femurs, tibiae, and
iliac crests, and PB was isolated via the retro-orbital plexus. Whole PB differ-
ential counts were determined with an AcT10 analyzer (Beckman Coulter).
RBCs were lysed with ammonium chloride buffer prior to staining. Fluoro-
chrome-conjugated antibody clones were obtained from eBioscience: Gr-1448 Cell Stem Cell 5, 442–449, October 2, 2009 ª2009 Elsevier Inc.(RB6-8C5), CD11b (M1/70), F4/80 (BM8), IgM (II/4I), CD43 (S7), B220 (RA3-
6B2), CD71 (R17217), Ter-119, CD4 (GK1.5), CD8a (53-6.7). Flow cytometric
analysis was performed on a FACSCalibur (Becton Dickinson, BD) and all
data were analyzed with FlowJo (Tree Star, Inc.).
Bone Marrow Transplantation Analysis
Congenic female B6.SJL (CD45.1+) mice (Taconic Farms) were irradiated with
a split dose of 11 Gy and injected with 2 3 106 whole BM cells from Dnmtfl/fl
Cre or Cre+ mice (CD45.2+). The PB chimerism of recipient mice was as-
sessed with fluorochrome-conjugated antibodies against CD45.1 (A20),
CD45.2 (104) (eBioscience), and multilineage antibodies as described. For
secondary transplants, 9 3 105 CD45.2+ donor cells from primary recipients
were injected into lethally irradiated, secondary CD45.1+ recipients. For
competitive transplantation, competitor BM cells were obtained from the
first-generation cross of C57BL/6 and B6.SJL mice. Dnmtfl/fl Cre or Cre+
BM cells were coinjected with competitor BM cells at a ratio of 1:1 (2 3 106
cells each). For secondary competitive transplantation, 93 105 FACS-isolated
donor CD45.2+ cells were coinjected with 3 3 105 freshly isolated competitor
CD45.1+CD45.2+ BM cells. For nonablative transplant, 40 3 106 BM cells or
5000 purified Linc-Kit+Sca-1+CD34/lo LT-HSCs from CD45.1+CD45.2+
mice were retro-orbitally injected into control or Dnmt1D/D mice. Donor cell
engraftment was determined at 12 weeks posttransplant.
Hematopoietic Stem and Progenitor Cell Homing Assay
LinSca-1+ cells were isolated from control or Dnmt1D/D BM, labeled with
-5(and -6)-carboxyfluorescein diacetate succinimidyl ester (CFSE, Molecular
Probes), and washed, and 2 3 105 cells were transplanted retro-orbitally
into lethally irradiated mice. After 16 hr, BM cells were isolated from the femurs,
tibiae, and iliac crests of recipient mice, and CFSE+ cells detected
by collection of at least 5 3 106 live events per sample on a FACSAria (BD).
Analysis of Hematopoietic Stem and Progenitor Cells
Lineage depletion of BM, spleen, or PB cells from control or Dnmt1D/D mice
was performed as described by the manufacturer (Dynabeads Sheep anti-
Rat IgG, Invitrogen) with affinity-purified rat anti-mouse antibodies (eBio-
science) against CD33, CD4, CD5, CD8a, B220, Gr-1, CD11b, Ter119.
Lineage-depleted cells were stained with fluorochrome-conjugated antibodies
(eBioscience) recognizing CD117 (c-Kit; 2B8), Sca-1 (E13-161.7), CD34
(RAM34), CD16/CD32 (FcgIII/II Receptor; 2.4G2), and CD127 (IL-7Ra;
A7R34) and analyzed on a LSRII (BD). Colony-forming unit (CFU) assays
were performed by plating cells into MethoCult GF M3434 (StemCell Technol-
ogies) and scoring colonies after 10 days. To assess cell cycling, mice were
injected with 200 ml of 10 mg/mL 5-bromo-2-deoxyuridine (BrdU) by IP injec-
tion and sacrificed 12 hr later. Cell cycle status was determined by incorpora-
tion of BrdU and 7-AAD as described by the manufacturer (BrdU Flow Kit, BD
PharMingen).
Global Gene Expression Analysis
Purified Linc-Kit+Sca-1+CD34/lo LT-HSCs (two replicates), Linc-Kit+
Sca-1+CD34+ ST-HSC/MPPs (two replicates), and Linc-Kit+Sca-1 myeloid
progenitors (three replicates) were isolated by FACSAria (BD) to >97% purity
from control or Dnmt1D/D mice. Total RNA was extracted with the RNeasy
Micro Kit (QIAGEN), treated with DNaseI, reverse transcribed, and amplified
with the WT-Ovation Pico RNA Amplification System (NuGEN Technologies).
Single-stranded cDNA amplification products were purified with QIAquick
PCR Purification Kit (QIAGEN) and labeled with the FL-Ovation cDNA Biotin
Module V2 (NuGEN). Hybridization to GeneChip Mouse Genome 430A 2.0
Arrays (Affymetrix), washing, and scanning were performed by the DFCI Micro-
array Core Facility (Boston, MA). CEL files were imported into dChIP software
(Schadt et al., 2001) for data normalization and extraction of signal intensities.
Independent biological repeats were combined by averaging the signal inten-
sities of each probe represented on the microarray. Probes with an averaged
signal intensity of >100 from at least one of the repeats were further analyzed
(a total of 8723 probes).
Gene Ontology Analysis
Gene ontology (GO) analysis was performed with DAVID (Dennis et al.,
2003). The top 10% upregulated and downregulated genes in the LT-HSC,
Cell Stem Cell
Dnmt1 Regulates HSCs and Progenitor CellsST-HSC/MPP, and myeloid progenitor gene sets were annotated for GO
terms. GO terms with enrichment scores larger than 2 and p values less
than 1E-4 were considered significant.
Quantitative Real-Time PCR
RNA was isolated from cells with the RNeasy Micro Kit (QIAGEN) and treated
with DNaseI prior to reverse transcription. cDNA was prepared with Super-
Script III (Invitrogen). Semiquantitative real-time PCR was performed with iQ
SYBR Green mix (Bio-Rad) on an iCycler (Bio-Rad) and Ct values were normal-
ized to b-actin levels.
Statistical Analyses
Statistical analyses were performed with unpaired Student’s t tests.
ACCESSION NUMBERS
Raw data from the Affymetrix microarray expression profiling were deposited
in the Gene Expression Omnibus under accession number GSE15840.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, six
figures, and two tables and can be found with this article online at http://
www.cell.com/cell-stem-cell/supplemental/S1934-5909(09)00400-7.
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